An interventional study of Focused Extracorpeal Shock wave and Sham Extracorpeal shock wave in Cervical Radiculopathy, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 36 Years to 46 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 36 studies in Radiculopathy by Cairo University — 22 open to participants now, 22 under way, none of them phase 3. Radiculopathy · Cairo University.
Among the 36 studies in Radiculopathy by Cairo University, this one has the largest planned enrollment of the 27 interventional ones that give a count, is one of 13 that started in 2026, is one of 26 with no phase, reaches primary completion later than 15 of the 21 other live ones, and was the 7th registered.
488 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.
Browse Radiculopathy studies →22 of the 36 studies in Radiculopathy by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 25–44
Cairo University · Sites in Egypt
Ages 35–50 · Men only
Cairo University · Sites in Egypt
Ages 40–60
Cairo University · Sites in Egypt
Ages 40–55
Cairo University · Sites in Egypt
Ages 20–60
By country, each count listing its studies:
Of the 79 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 48 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.
This study: 36 Years to 46 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2019; this study’s year is marked. 13 started in 2026.
This study's planned enrollment of 80 is above the median of 60 across 375 interventional studies indexed under Radiculopathy.
Median enrollment 45 across the 27 interventional studies, 66 across the 9 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
5 of the studies in Radiculopathy by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07906847Cairo UniversityCorrelation Between Forward Head Posture and Executive Functions in Cervical Radiculopathy | 2027-01 |
| NCT07841405Cairo UniversityEffect of Transfer of Energy Capacitive and Resistive on Chronic Discogenic Sciatica | 2027-01-21 |
| NCT07949279Cairo UniversityMovement Patterns and Balance in People With Lumbar Radiculopathy | 2027-02-28 |
| NCT07946133Cairo UniversityELDOA Versus GPR Exercises in Cervical Radiculopathy | 2027-04-30 |
| NCT07817992Cairo UniversityEffect of Virtual Reality- Based Training on Cervical Mobility, Proprioceptive Accuracy and Hand Grip Strength in Patients With Cervical Radiculopathy | 2027-07-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 36 studies in Radiculopathy by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
BACKGROUND: Upper limb nerve root dysfunction with increased active myofascial trigger point in upper trapezius is common problem in patients with cervical radiculopathy.
The purpose of this study was to evaluate the effect of Extracorpeal shock wave on the myo-electric and nerve function responses in patients with cervical radiculopathy.
Randomized controlled clinical trial among Forty eight (48) patients with cervical radiculopathy.
They will be allocated randomly by sealed envelopes into two groups: Group (A): will receive a designed physical therapy program in addition to sham Extracorpeal shock wave on upper trapezius. Group (B): will receive Focused Extracorpeal shock wave on the active myofascial trigger points in upper trapezius in addition to the same physical therapy program as in group A.
Somatosensory evoked potential for upper limb median nerve will be applied using the Electromyography (EMG) device. Hand grip strength will be assessed using the handheld dynamometer (HHD) , Level of radiating pain will be assessed using the numeric rating scale , Pain and tenderness in upper trapezius muscle will be also assessed using Pressure pain threshold (PPT).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Control group (GA) Patients in (GA) will be treated by a designed physiotherapy program consisted of Myo-fascial release, stretching exercise, Proprioceptive neuromuscular facilitation (PNF) techniques, Median nerve neural glide techniques, Graduated strengthening exercises for the upper limb in addition to sham shockwave on the upper trapezius.
Device: Sham Extracorpeal shock wave
Patients in (GB) will be treated by Focused Extracorpeal shockwave on the trigger points of upper trapezius in addition to the same physiotherapy program as GA.
Device: Focused Extracorpeal Shock wave
Focused Extracorporeal shock wave for 700 impulses of 0.056 mJ/mm at a frequency of 10 Hz to the taut band and 300 impulses surrounding the taut band was applied as low energy 2 sessions per week for 4 weeks. (EME S.r.l. via Degli Abeti 88/161122 Pesaro \[serial number: EM12681015\], Italy) was used as a focused extracorporeal shock wave therapy apparatus.
(EME S.r.l. via Degli Abeti 88/161122 Pesaro \[serial number: EM12681015\], Italy) was used as a focused extracorporeal shock wave therapy apparatus. The device will be used in the demo mood with no radiation or impulses applied.
Amplitude of median nerve dermatomal somatosensory evoked potential
After the stimulation was performed and the traces were superimposed to ensure reproducibility, negative near field potential were detected and positive peak was detected to measure the peak to peak amplitude. This amplitude was measured. The distance between positive and negative peak , it is measures in millivolts (mV)
Time frame: Baseline Assessment and Immediately Post Treatment.
Distal Latency of median nerve dermatomal somatosensory evoked potential
Distal latency is defined as the interval between the stimulation of a compound muscle or selective dermatome and the observed response. It is measured in meter per second (m/s)
Time frame: Baseline Assessment and Immediately Post Treatment.
Pain Pressure Threshold on upper trapezius
Pain pressure Threshold (PPT) device will be used to detect tenderness and pain on the active myofascial trigger points on upper trapezius muscle. The 1-cm² rubber tip was applied perpendicularly over the myofascial trigger points and the power is switched on; a required pressure will be exerted on the site of myofascial trigger points by pressing the transducers firmly downwards. Measurements were recorded in kilograms of pressure per square centimeter (kg/cm\^2).
Time frame: Baseline Assessment and Immediately Post Treatment.
Hand grip Strength
Jamar hydraulic hand dynamometer will be used, it is a quantitative and an objective measure of the isometric muscular strength of the hand grip. It is a portable dynamometer used as a valid and reliable tool to reflect the upper limb strength. This instrument is scored using force production in kilograms (0-90) or pounds (0-200). Maximum grip was the mean of three trials. For each patient the both sides were assessed before treatment to collect the normative value for each patient. Mean of Maximum grip was compared pre and post treatment for each patient
Time frame: Baseline Assessment and Immediately Post Treatment.
Level of radiating pain
Numeric rating Scale (NRS) for pain will be used to assess level of pain radiating through the upper limb. Patients are asked to circle the number between 0 and 10 that fits best to their pain intensity . Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.
Time frame: Baseline Assessment and Immediately Post Treatment.
Plan to share: No
No publications or documents are linked to this record.
Started May 2026 (actual). Primary completion is estimated for Nov 2026, 5 months after the start.
Of 205 non-industry interventional studies with no phase under Radiculopathy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's planned 5 months is below that.
Counting every sponsor, half of 217 studies reached it within 12 months; a quarter within 5 and three quarters within 41.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: start Apr 2025 → May 2026, primary completion Nov 2025 → Nov 2026 and completion Jan 2026 → Nov 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.